We are focused on developing important new therapies that provide meaningful benefit to pet patients.

​

Aniluxx is committed to identifying the unmet needs of pet patients living with chronic conditions and harnessing scientific advances to develop differentiated, novel therapies that address the needs of these patients.

​

With our deep insight in biology, and our thorough understanding of unmet patient needs, we are developing a portfolio of unique therapies to elevate the standard of care for pet patients living with chronic conditions.

​